Genedrive (GDR)

Sector:

Health Care

Index:

FTSE AIM All-Share

 3.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 22.25
  • 52 Week Low: 3.13
  • Currency: UK Pounds
  • Shares Issued: 143.14m
  • Volume: 2,820,795
  • Market Cap: £5.01m
  • RiskGrade: 747

Latest ShareCast News

Genedrive shares jump on NICE test recommendation

By Josh White

Date: Wednesday 03 Apr 2024

(Sharecast News) - Genedrive shares were surging on Wednesday, after it received a significant endorsement from the UK's National Institute for Health and Care Excellence (NICE) regarding its 'CYP2C19-ID' test.

Genedrive receives R&D tax credit, plans fundraise

By Josh White

Date: Friday 15 Mar 2024

(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive announced the receipt of a research and development tax credit totalling £0.8m on Friday, taking its unaudited cash balances to £1.2m.

Genedrive set to apply for NICE EVA funding

By Josh White

Date: Monday 19 Feb 2024

(Sharecast News) - Genedrive shares rose on Monday, on the launch of the NICE early value assessment (EVA) evidence generation funding call, backed by the National Institute for Health and Care Research (NIHR).

Genedrive confirms £0.6m equity prepayment drawd... 02-Jan-2024 ShareCast
Genedrive gets first product orders from several... 20-Dec-2023 ShareCast
Genedrive diagnostic test system gets UKCA regis... 06-Sep-2023 ShareCast
Genedrive draws down £0.3m under equity prepayme... 05-Jul-2023 ShareCast
Genedrive secures multi-partner grant award 16-Jun-2023 ShareCast
Genedrive jumps on draft NICE testing guidance 19-May-2023 ShareCast
Genedrive engages with US FDA over infant test 05-Oct-2022 ShareCast
Genedrive test to go through new, faster NICE pr... 26-Sep-2022 ShareCast
Another Genedrive test to be assessed by NICE 22-Aug-2022 ShareCast
Genedrive test to be evaluated by NICE 16-Jun-2022 ShareCast
Genedrive rallies on positive news about hearing... 29-Mar-2022 ShareCast
Genedrive finance chief announces April departure 02-Mar-2022 ShareCast
Genedrive makes progress with rapid Covid-19 tes... 23-Feb-2022 ShareCast
Genedrive submits new Covid-19 test for EU certi... 29-Nov-2021 ShareCast
Revenues fall, losses narrow for Genedrive 09-Nov-2021 ShareCast
Genedrive gets CE-IVD marking for new system pla... 29-Sep-2021 ShareCast
Genedrive to seek CE mark clearance for MT-RNR1 ... 31-Aug-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genedrive Market Data

Currency UK Pounds
Share Price 3.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 22.25
52 Week Low 3.13
Volume 2,820,795
Shares Issued 143.14m
Market Cap £5.01m
RiskGrade 747

Genedrive Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.64% below the market average33.64% below the market average33.64% below the market average33.64% below the market average33.64% below the market average
12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average
Price Trend
94.46% below the market average94.46% below the market average94.46% below the market average94.46% below the market average94.46% below the market average
78.38% below the sector average78.38% below the sector average78.38% below the sector average78.38% below the sector average78.38% below the sector average
Income Not Available
Growth
43.98% below the market average43.98% below the market average43.98% below the market average43.98% below the market average43.98% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average

Genedrive Dividends

No dividends found

Trades for 09-May-2024

Time Volume / Share Price
16:21 34,325 @ 3.40p
16:21 173,913 @ 3.45p
16:20 151,745 @ 3.30p
16:18 289,855 @ 3.45p
16:13 10,000 @ 3.30p

Genedrive Key Personnel

CFO Russell Shaw
CEO James Cheek

Top of Page